Guides for Oncology Providers and Patients Now Available

Get Permission

As the prevalence of obesity increases in the U.S. population and potentially complicates all aspects of cancer treatment and survival, many cancer care providers struggle with addressing the topics of weight loss and weight management with their patients. Obesity and Cancer: A Guide for Oncology Providers is a tool for oncology professionals developed by a multidisciplinary group of cancer, nutrition, and exercise science experts. This guide will help oncology providers integrate strategies for weight loss into their practices by offering practical tips and implementation strategies for weight assessment and weight loss, as well as information about how to be reimbursed for these services. The obesity and cancer provider guide is funded through the Conquer Cancer Foundation with the generous support of Roche and Ethicon Endo-Surgery.

To complement the provider guide, this bundle also includes Managing Your Weight After a Diagnosis of Cancer: A Guide for Patient and Families. This booklet provides clear, practical information especially for patients and their caregivers about different weight loss methods, common challenges to losing and maintaining one’s weight, a discussion of the emotional challenges that accompany making lifestyle changes, and tips for talking with the health-care team about weight. Both the provider and the patient guides are now available on ASCO’s website, at ■

Related Articles

Obesity Increases Breast Cancer Mortality in Premenopausal Women With Estrogen Receptor–Positive Disease

According to results of a large study of women with early breast cancer, the presence of obesity increased the risk of breast cancer–related mortality by 34% in premenopausal women with estrogen receptor–positive breast cancer. Obesity had little effect on breast cancer–related mortality in...

Expert Point of View: Clifford A. Hudis, MD, FACP

“To our surprise, obesity had a negative prognostic effect on premenopausal patients with breast cancer but not on those who were postmenopausal. We need to consider these findings in the context of results from other data sources that suggest that obesity remains a negative prognostic feature in...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.